Argent Biopharma Ltd has released a press release.
CannEpil Global Licence Expands into Veterinary Healthcare
Earlier from Argent Biopharma
- RGT Executes Global CannEpil Licensing Deal for US$5.5M
- Half Yearly Report and Accounts
- Provisional Patent Lodged with USPTO for NanoBodies Platform
- CannEpil - Largest Commercial Shipment Arrives in Ireland